Mulligan Mobilization in Rheumatoid Hand

Launched by KIRSEHIR AHI EVRAN UNIVERSITESI · Dec 13, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called Mulligan mobilization to see if it can help people with rheumatoid arthritis (RA) who have swelling in their wrist joints. The main question the researchers want to answer is whether this treatment can reduce the swelling and improve movement in the hands of those affected by RA. Participants will receive either the Mulligan mobilization treatment along with exercises for their hands or a similar treatment that does not provide the same benefits, known as sham mobilization.

To be eligible for this study, participants must have been diagnosed with rheumatoid arthritis and have been under the care of a specialist for at least a year. They should not have had any surgery on their arms or hands in the past six months and must be able to follow instructions. It's important to note that individuals with certain hand injuries or other specific health conditions will not be able to participate. If you join the trial, you can expect to take part in treatments and exercises that could help improve your hand function and reduce swelling. The study is currently recruiting participants of all genders aged between 18 to 80 years old.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Having been diagnosed with RAS according to ACR and EULAR criteria,
• • Being under the control of a physiatrist for at least 1 year,
• • Have not had any upper extremity surgery in the last 6 months
• • Have the cognitive capacity to understand commands,
• • Not to be involved in any other rehabilitation program or study,
• Exclusion Criteria:
• • Presence of soft tissue injury and chronic bone damage in the hand,
• • Presence of acute inflammation in any joint in the previous week,
• • Presence of a degenerative or non-degenerative neurological condition that causes a change in pain perception,

Trial Officials